Saturday, October 18, 2025
  • Hype
  • Murai
  • Lipstiq
  • Miss Murai
  • Varnam
  • Moviedash
  • Autofreaks
Lowyat.NET
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Compu-zoneUpdated
    • ViewnetUpdated
    • Sri ComputersUpdated
    • StartecUpdated
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables
No Result
View All Result
Lowyat.NET
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Compu-zoneUpdated
    • ViewnetUpdated
    • Sri ComputersUpdated
    • StartecUpdated
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables
No Result
View All Result
Lowyat.NET
No Result
View All Result
Home Coronavirus

Malaysia Gives Conditional Approval For Pfizer’s Paxlovid COVID-19 Drug (UPDATED)

Another treatment in the country's arsenal against the virus.

by Ikmal Rozlan
March 4, 2022
pfizer paxlovid covid-19 treatment pills

Pfizer's Paxlovid antiviral pills. [Photo: Pfizer]

532
SHARES
Share on FacebookShare on Twitter

UPDATE (5 MAR / 4:20 PM): Health Minister Khairy Jamaluddin has confirmed that Malaysia will receive 110,000 patient-courses of Paxlovid in two weeks. As for the treatments from Merck and AstraZeneca, the government also has plans to buy them but it has not been finalised yet.

ORIGINAL STORY (4 MAR / 1:25 PM):

Director-General of Health Dr Noor Hisham Abdullah has announced that the Drug Control Authority (DCA) has given conditional approval for the Paxlovid COVID-19 treatment drug made by pharmaceutical firm Pfizer. The product registration holder is Pfizer Malaysia and it is only approved for use on adults over 18 with a high risk of contracting severe symptoms from the virus.

Paxlovid is a combination treatment using nirmatrelvir and ritonavir, taken orally and has been shown in clinical trials to be highly effective at preventing hospitalisation and death. Dr Noor Hisham reminded the public that the treatment is not a replacement for the vaccine and people should still do their best to follow SOPs.

Paxlovid’s packaging for the US market. [Image: Pfizer / FDA – pdf.]

The Ministry of Health (MoH) had already announced back in December that it was planning to procure the drug for use here, but did not reveal how many courses will be purchased. Aside from Paxlovid, Malaysia also plans to buy treatment drugs from AstraZeneca and Merck, although the latter will only submit its pill for approval sometime this year. Another COVID-19 treatment called Ronapreve is also already in use in Sarawak.

The Pfizer treatment has already been approved in the US, UK, the European Union, Israel, South Korea, Canada, China, and Singapore. The price of the drugs have not been revealed, but for reference, it cost the US government US$530 (~RM2200) for each five-day course which is cheaper than Merck’s molnupiravir at US$700 (~RM2900) for a five-day course.

(Source: Director-General of Health.)

Filed Under COVID-19Drugpaxlovidpfizertreatment
Updated 4:24 pm, Sat, 5 March 22
http://lowy.at/MaQ2V
Share213Tweet133SendShare

Follow us on Instagram, Facebook, Twitter or Telegram for more updates and breaking news. 

No Result
View All Result

TRENDING THIS WEEK

  1. 1
    Apps

    Selangor Government Launches “Nine”, Its All-In-One App

  2. 2
    News

    47th ASEAN Summit: Major Road Closures In KL From 26 to 28 October 2025

  3. 3
    Social Media

    Fahmi: Malaysia To Enforce eKYC Verification For Social Media Platforms

  4. 4
    Automotive

    Blueshark Malaysia Launches All-New SoleEra Solo 2; Priced At RM6,399

  5. 5
    Mobile Phones

    Nubia Air Launching In Malaysia On 17 October

NETWORK

  • Hype
  • Murai
  • Lipstiq
  • Miss Murai
  • Varnam
  • Moviedash
  • Autofreaks

ABOUT

  • Advertise
  • Careers
  • Privacy Statement
  • Contact Us
  • Editorial Policy
  • Terms & Conditions

©2025 VIJANDREN RAMADASS. ALL RIGHTS RESERVED.

No Result
View All Result
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Compu-zone
    • Viewnet
    • Sri Computers
    • Startec
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables

©2025 VIJANDREN RAMADASS. ALL RIGHTS RESERVED.

No Result
View All Result
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Compu-zone
    • Viewnet
    • Sri Computers
    • Startec
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables

©2025 VIJANDREN RAMADASS. ALL RIGHTS RESERVED.